Pluri Inc. Proceeds from Sale of Short-term Investments
Pluri Inc. (PLUR) reported Proceeds from Sale of Short-term Investments of $898.00 thousand for the 12-month period ending 2011-06-30, per its 10-K filed 2013-09-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfShortTermInvestments · last filed 2013-09-11
- Pluri Inc. proceeds from sale of short-term investments for the quarter ending 2011-06-30 was $0.00.
- Pluri Inc. proceeds from sale of short-term investments for the quarter ending 2011-03-31 was $0.00.
- Pluri Inc. proceeds from sale of short-term investments for the quarter ending 2010-12-31 was $498.00K.
- Pluri Inc. proceeds from sale of short-term investments for the quarter ending 2010-09-30 was $400.00K.
- Pluri Inc. proceeds from sale of short-term investments for fiscal 2011 was $898.00K, a 43.95% decline from fiscal 2010.
- Pluri Inc. proceeds from sale of short-term investments for fiscal 2010 was $1.60M.
| Period end | Proceeds from Sale of Short-term Investments 3 month | Proceeds from Sale of Short-term Investments 6 month | Proceeds from Sale of Short-term Investments 9 month | Proceeds from Sale of Short-term Investments 12 month |
|---|---|---|---|---|
| 2011-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $0.00 derived: sum of 2 quarters · filed 2013-09-11 | $498.00K derived: sum of 3 quarters · filed 2013-09-11 | $898.00K 10-K · filed 2013-09-11 |
| 2011-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-08 | $498.00K derived: sum of 2 quarters · filed 2012-05-08 | $898.00K 10-Q · filed 2012-05-08 | |
| 2010-12-31 | $498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | $898.00K 10-Q · filed 2012-02-09 | ||
| 2010-09-30 | $400.00K 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | $1.60M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |